Metraipolis › archive › dc_4890e177e4bf
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data — Europe PMC PMID:40990044
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40990044
- DOI
- 10.1111/dom.70151
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:23:22.410Z
- SHA-256 of the archived text
d327458c3c82cd7e8fa864c74a47dcf35165d19e7f7bd16c1657dc3b02f8171b- Stable URL of this page
https://metraipolis.com/documento/dc_4890e177e4bf
How to cite
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data — Europe PMC PMID:40990044 — Europe PMC (en), https://europepmc.org/article/MED/40990044 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4890e177e4bf (Metraipolis archive dc_4890e177e4bf, sha256 d327458c3c82cd7e8fa864c74a47dcf35165d19e7f7bd16c1657dc3b02f8171b)
BibTeX
@misc{dc4890e177e4bf,
title = {Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data — Europe PMC PMID:40990044},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40990044},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4890e177e4bf; sha256 d327458c3c82cd7e8fa864c74a47dcf35165d19e7f7bd16c1657dc3b02f8171b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40990044. Agents can read the archived copy with the MCP tool read_document.